165 related articles for article (PubMed ID: 1691232)
1. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
Young JD; Jiang S; Liu CC; Hasselkus-Light CS
J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
[TBL] [Abstract][Full Text] [Related]
2. The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.
Young JD; Rosse WF; Hasselkus-Light CS
Biochem Biophys Res Commun; 1990 Jan; 166(2):648-52. PubMed ID: 2302230
[TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin.
Jiang S; Persechini PM; Rosse WF; Perussia B; Young JD
Biochem Biophys Res Commun; 1989 Jul; 162(1):316-25. PubMed ID: 2751655
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
Zalman LS; Wood LM; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
[TBL] [Abstract][Full Text] [Related]
5. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
Hänsch GM; Schönermark S; Roelcke D
J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
[TBL] [Abstract][Full Text] [Related]
6. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
Jiang S; Persechini PM; Perussia B; Young JD
J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
[TBL] [Abstract][Full Text] [Related]
7. The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains.
Young JD; Liu CC; Leong LG; Cohn ZA
J Exp Med; 1986 Dec; 164(6):2077-82. PubMed ID: 3537195
[TBL] [Abstract][Full Text] [Related]
8. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
Zalman LS; Müller-Eberhard H
Mol Immunol; 1994 Mar; 31(4):301-5. PubMed ID: 8139583
[TBL] [Abstract][Full Text] [Related]
9. Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
Blaas P; Berger B; Weber S; Peter HH; Hänsch GM
J Immunol; 1988 May; 140(9):3045-51. PubMed ID: 3361126
[TBL] [Abstract][Full Text] [Related]
10. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
Schönermark S; Rauterberg EW; Shin ML; Löke S; Roelcke D; Hänsch GM
J Immunol; 1986 Mar; 136(5):1772-6. PubMed ID: 2419413
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of the complement-regulatory factor C8 binding protein (C8bp) on U937 cells after stimulation with IL-1 beta, endotoxin, IFN-gamma, or phorbol ester.
Schieren G; Janssen O; Hänsch GM
J Immunol; 1992 May; 148(10):3183-8. PubMed ID: 1578143
[TBL] [Abstract][Full Text] [Related]
12. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
Tschopp J; Masson D; Schäfer S; Peitsch M; Preissner KT
Biochemistry; 1988 May; 27(11):4103-9. PubMed ID: 2458130
[TBL] [Abstract][Full Text] [Related]
13. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
Schönermark S; Filsinger S; Berger B; Hänsch GM
Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.
Zalman LS; Wood LM; Frank MM; Müller-Eberhard HJ
J Exp Med; 1987 Feb; 165(2):572-7. PubMed ID: 2434597
[TBL] [Abstract][Full Text] [Related]
15. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
Tschopp J; Masson D; Stanley KK
Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
[TBL] [Abstract][Full Text] [Related]
16. C8 binding protein bears I antigenic determinants.
Blaas-Mautner P; Filsinger S; Berger B; Roelcke D; Hänsch GM
Ann Hematol; 1991; 62(2-3):64-7. PubMed ID: 1903311
[TBL] [Abstract][Full Text] [Related]
17. Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C.
Hänsch GM; Weller PF; Nicholson-Weller A
Blood; 1988 Sep; 72(3):1089-92. PubMed ID: 3416071
[TBL] [Abstract][Full Text] [Related]
18. Absence of homologous restriction factor does not affect CTL-mediated cytolysis.
Krähenbühl OP; Peter HH; Tschopp J
Eur J Immunol; 1989 Jan; 19(1):217-9. PubMed ID: 2784107
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
20. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
